menu
techminis

A naukri.com initiative

google-web-stories
Home

>

Bio News

>

Revolution...
source image

Bioengineer

3d

read

155

img
dot

Image Credit: Bioengineer

Revolutionizing Prostate Cancer Treatment: Perspectives from Leading Chinese Experts

  • Prostate cancer is increasingly becoming a significant health concern in China that poses various challenges in the management and treatment of this disease.
  • A comprehensive consensus was developed, aimed at addressing critical gaps in prostate cancer management, covering the stages of screening, treatment, and follow-up care for patients throughout China.
  • The consensus was published in the journal UroPrecision on 10th Oct 2024, focusing on 19 pivotal questions, covering various aspects of prostate cancer management.
  • The consensus highlights the importance of early detection in combating the disease, with 89% of the participating experts underscoring the efficacy of PSA screening in reducing prostate cancer-specific mortality rates.
  • The consensus advocates for the incorporation of next-generation hormonal agents in combination with androgen deprivation therapy (ADT) to tackle the aggressive nature of metastatic forms of the disease.
  • 75% of experts concurred that additional assessments should be pursued in cases where standard imaging fails to reveal metastasis.
  • The consensus recommends initiating PSA screening at the age of 50 for men who do not have a family history of prostate cancer or carry BRCA2 mutations.
  • The recommendations aim to foster a more structured approach to managing prostate cancer, ensuring healthcare professionals are equipped with knowledge to confront prostate cancer effectively.
  • This consensus could serve as a vital instrument in fighting against this growing health threat, paving the way for improved care and treatment methodologies that could ultimately reduce the burden of the disease.
  • The consensus published in UroPrecision marks a crucial advance in prostate cancer management in China, aimed at improving patient care and addressing the immediate needs of those affected by prostate cancer.

Read Full Article

like

9 Likes

For uninterrupted reading, download the app